How do I get UnitedHealthcare to cover GLP-1 medications?

UnitedHealthcare typically requires prior authorization for GLP-1 medications like Ozempic, Wegovy, and Mounjaro. To get coverage, your doctor must submit documentation of medical necessity including your BMI, comorbidities (such as type 2 diabetes or cardiovascular disease), and evidence that other treatments have been tried. UnitedHealthcare covers most GLP-1 medications with prior authorization. Weight loss indications require documented BMI >= 30 or >= 27 with comorbidities. Plans vary significantly by employer.

What should I do if my GLP-1 prior authorization is denied?

If your GLP-1 prior authorization is denied, request a copy of the denial letter with the specific reason for denial. Work with your doctor to prepare an appeal with additional clinical evidence of medical necessity. You can also request a peer-to-peer review between your doctor and the insurer's medical director. Use MedicalRecords.com's Undeniable tool to generate a professional appeal letter.

How long does it take to get prior authorization for GLP-1 medications?

Standard prior authorization decisions are required within 72 hours for urgent requests and within 3-14 days for non-urgent requests, depending on state law and your plan type. Expedited appeals (when delay would seriously jeopardize your health) must be decided within 72 hours. Denials can be appealed through internal and external review processes.

Request Records

Start Your Appeal

UnitedHealthcare GLP-1 Coverage

UnitedHealthcare covers most GLP-1 medications with prior authorization. Weight loss indications require documented BMI >= 30 or >= 27 with comorbidities. Plans vary significantly by employer.

7/9

Medications Covered

commercial

Plan Type

Ashwin Philips

Reviewed by George T. MathewMDMBAFACP on February 1, 2026

Does UnitedHealthcare cover GLP-1 medications like Ozempic and Wegovy?

UnitedHealthcare covers 7 of 9 major GLP-1 medications (with prior authorization or directly). UnitedHealthcare covers most GLP-1 medications with prior authorization. Weight loss indications require documented BMI >= 30 or >= 27 with comorbidities. Plans vary significantly by employer. Scroll down for detailed coverage status, copay estimates, denial rates, and appeal success rates for each medication.

Coverage Details

GLP-1 Medications Covered by UnitedHealthcare

Ozempic

semaglutide | Novo Nordisk

Prior Authorization Required

Typical Copay$25-$75/month

Denial Rate25-35%

Appeal Success45-55%

Requirements

Type 2 diabetes diagnosis
Prior metformin trial
A1C documentation

Covered for diabetes. Off-label weight loss use frequently denied.

Wegovy

semaglutide | Novo Nordisk

Prior Authorization Required

Typical Copay$50-$150/month

Denial Rate40-50%

Appeal Success35-45%

Requirements

BMI >= 30 or >= 27 with comorbidity
Failed lifestyle modification
Documented weight history

Coverage varies widely by employer plan. Many plans exclude weight loss medications entirely.

Mounjaro

tirzepatide | Eli Lilly

Prior Authorization Required

Typical Copay$25-$75/month

Denial Rate30-40%

Appeal Success40-50%

Requirements

Type 2 diabetes diagnosis
Failed GLP-1 or metformin
A1C >= 7%

Preferred on some UHC formularies for diabetes. Step therapy may require trying Ozempic first.

Zepbound

tirzepatide | Eli Lilly

Prior Authorization Required

Typical Copay$50-$150/month

Denial Rate45-55%

Appeal Success30-40%

Requirements

BMI >= 30 or >= 27 with comorbidity
Failed lifestyle modification
No active eating disorder

Newer medication with limited formulary placement. Many employer plans have not yet added coverage.

Rybelsus

semaglutide (oral) | Novo Nordisk

Prior Authorization Required

Typical Copay$25-$50/month

Denial Rate20-30%

Appeal Success50-60%

Requirements

Type 2 diabetes diagnosis
Prior metformin trial

Oral formulation may be preferred on some formularies due to lower cost.

Saxenda

liraglutide | Novo Nordisk

Varies by Plan

Typical Copay$50-$150/month

Denial Rate50-60%

Appeal Success25-35%

Requirements

BMI >= 30 or >= 27 with comorbidity
Failed lifestyle modification

Being phased out in favor of newer weekly options. Coverage declining across plans.

Trulicity

dulaglutide | Eli Lilly

Covered

Typical Copay$25-$50/month

Denial Rate10-15%

Appeal Success65-75%

Requirements

Type 2 diabetes diagnosis

Widely covered for diabetes with low denial rates. Often a preferred step-therapy option.

Victoza

liraglutide | Novo Nordisk

Covered

Typical Copay$25-$50/month

Denial Rate10-15%

Appeal Success65-75%

Requirements

Type 2 diabetes diagnosis

Well-established coverage. May be required as step therapy before newer GLP-1 medications.

Compounded Semaglutide

semaglutide (compounded) | Various Compounding Pharmacies

Not Covered

Typical CopayN/A

Denial Rate100%

Appeal Success0%

Not covered by any UHC plan. Compounded medications are not FDA-approved.

Prior Authorization

UnitedHealthcare Prior Authorization Process

Prior authorization is required for all GLP-1 medications. Submit via UHC provider portal or fax. Decision typically within 5-7 business days. Expedited review available for urgent cases.

Appeals

How to Appeal a UnitedHealthcare GLP-1 Denial

Internal appeal within 180 days of denial. Requires letter of medical necessity from prescriber. External review available through state insurance department after internal appeal exhaustion.

Contact Information

Provider Line: 1-877-842-3210 | Member Services: 1-800-328-5979

UnitedHealthcare GLP-1 denied? Our AI appeal tool can help.

Start Your Appeal Learn About Appeals

GLP-1 Medication Denied by Insurance?

You have the right to appeal. Our AI-powered appeal tool generates professional appeal letters with PubMed-cited evidence in minutes.

Start Your Free Appeal Appeal Guide

Disclaimer

Coverage information for UnitedHealthcare is based on publicly available formulary data and general plan information. Your specific plan may differ significantly. Always verify coverage directly with UnitedHealthcare before starting treatment.

Related resources

UnitedHealthcare GLP-1 Coverage

UnitedHealthcare covers most GLP-1 medications with prior authorization. Weight loss indications require documented BMI >= 30 or >= 27 with comorbidities. Plans vary significantly by employer.

7/9

Medications Covered

commercial

Plan Type

Ashwin Philips

Reviewed by George T. MathewMDMBAFACP on February 1, 2026

Does UnitedHealthcare cover GLP-1 medications like Ozempic and Wegovy?

Coverage Details

GLP-1 Medications Covered by UnitedHealthcare

Ozempic

semaglutide | Novo Nordisk

Prior Authorization Required

Typical Copay$25-$75/month

Denial Rate25-35%

Appeal Success45-55%

Requirements

Type 2 diabetes diagnosis
Prior metformin trial
A1C documentation

Covered for diabetes. Off-label weight loss use frequently denied.

Wegovy

semaglutide | Novo Nordisk

Prior Authorization Required

Typical Copay$50-$150/month

Denial Rate40-50%

Appeal Success35-45%

Requirements

BMI >= 30 or >= 27 with comorbidity
Failed lifestyle modification
Documented weight history

Coverage varies widely by employer plan. Many plans exclude weight loss medications entirely.

Mounjaro

tirzepatide | Eli Lilly

Prior Authorization Required

Typical Copay$25-$75/month

Denial Rate30-40%

Appeal Success40-50%

Requirements

Type 2 diabetes diagnosis
Failed GLP-1 or metformin
A1C >= 7%

Preferred on some UHC formularies for diabetes. Step therapy may require trying Ozempic first.

Zepbound

tirzepatide | Eli Lilly

Prior Authorization Required

Typical Copay$50-$150/month

Denial Rate45-55%

Appeal Success30-40%

Requirements

BMI >= 30 or >= 27 with comorbidity
Failed lifestyle modification
No active eating disorder

Newer medication with limited formulary placement. Many employer plans have not yet added coverage.

Rybelsus

semaglutide (oral) | Novo Nordisk

Prior Authorization Required

Typical Copay$25-$50/month

Denial Rate20-30%

Appeal Success50-60%

Requirements

Type 2 diabetes diagnosis
Prior metformin trial

Oral formulation may be preferred on some formularies due to lower cost.

Saxenda

liraglutide | Novo Nordisk

Varies by Plan

Typical Copay$50-$150/month

Denial Rate50-60%

Appeal Success25-35%

Requirements

BMI >= 30 or >= 27 with comorbidity
Failed lifestyle modification

Being phased out in favor of newer weekly options. Coverage declining across plans.

Trulicity

dulaglutide | Eli Lilly

Covered

Typical Copay$25-$50/month

Denial Rate10-15%

Appeal Success65-75%

Requirements

Type 2 diabetes diagnosis

Widely covered for diabetes with low denial rates. Often a preferred step-therapy option.

Victoza

liraglutide | Novo Nordisk

Covered

Typical Copay$25-$50/month

Denial Rate10-15%

Appeal Success65-75%

Requirements

Type 2 diabetes diagnosis

Well-established coverage. May be required as step therapy before newer GLP-1 medications.

Compounded Semaglutide

semaglutide (compounded) | Various Compounding Pharmacies

Not Covered

Typical CopayN/A

Denial Rate100%

Appeal Success0%

Not covered by any UHC plan. Compounded medications are not FDA-approved.

Prior Authorization

UnitedHealthcare Prior Authorization Process

Prior authorization is required for all GLP-1 medications. Submit via UHC provider portal or fax. Decision typically within 5-7 business days. Expedited review available for urgent cases.

Appeals

How to Appeal a UnitedHealthcare GLP-1 Denial

Internal appeal within 180 days of denial. Requires letter of medical necessity from prescriber. External review available through state insurance department after internal appeal exhaustion.

Contact Information

Provider Line: 1-877-842-3210 | Member Services: 1-800-328-5979

UnitedHealthcare GLP-1 denied? Our AI appeal tool can help.

Start Your Appeal Learn About Appeals

GLP-1 Medication Denied by Insurance?

You have the right to appeal. Our AI-powered appeal tool generates professional appeal letters with PubMed-cited evidence in minutes.

Start Your Free Appeal Appeal Guide